Skip to main content
. 2005 Sep;79(18):12088–12094. doi: 10.1128/JVI.79.18.12088-12094.2005

TABLE 1.

Quantification of GM1 recruitment to the VSa

JurkatLAI effector cell treatment % Conjugatesb % VSc % GM1 polarization nd
Untreated 42 47 63 129
β-CD treatment 35e 6 7 118
a

JurkatLAI effector T cells were either untreated or pretreated with 10 mM β-CD for 30 min at 37°C to deplete membrane cholesterol. Washed effector cells were mixed with primary CD4+ target T cells for 1 h at 37°C in the presence of L120 to stain CD4. Conjugates were fixed and stained at 4°C with B-Ctx to label GM1 and then permeabilized and stained for HIV Gag. Conjugates were subsequently analyzed by LSCM for VS formation and GM1 polarization.

b

The percentage of effector JurkatLAI cells in conjugates with primary CD4+ T cells was calculated by analyzing the number (n) of effector cells shown.

c

VS formation was defined as copolarization to the conjugate interface of CD4 on the target cell and of HIV antigens in the effector cell as described previously (16, 17).

d

n indicates the number of effector cells examined from randomly chosen low-power fields.

e

Value does not differ significantly (P < 0.05) from the control values as calculated using an unpaired two-tailed student t test.

HHS Vulnerability Disclosure